Keryx Biopharmaceuticals (Nasdaq: KERX) Agrees to acquire Accumin, a patent protected diagnostic for the direct measurement and quantitation of total ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE